Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Invasive Breast Cancer × cemiplimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 21 Squamous Cell Carcinoma of Head and Neck 9 Lung Neoplasms 7 Neoplasms 6 Melanoma 6 Carcinoma, Squamous Cell 5 Carcinoma 5 Adenocarcinoma 5 Skin Neoplasms 4 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Neoplasm Metastasis 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Breast Neoplasms 3 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2 Mesothelioma, Malignant 2 Laryngeal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Merkel Cell 2 Carcinoma, Hepatocellular 2 Carcinoma, Basal Cell 2 Adrenocortical Carcinoma 2 Vulvar Neoplasms 1 Vaccinia 1

Interventions

liposomal doxorubicin 1 cemiplimab 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡